The exacerbation of cutaneous psoriasis induced by anti - TNF therapy - case report
Abstract
Keywords
Full Text:
PDFReferences
Ko JM, Gottlieb AB, Kerbleski JF: Induction and exacerbation of psoriasis with TNF-blockade therapy: a review and analysis of 127 cases. J Dermatolog Treat, 2009, 20(2):100-8.
Joyau C, Veyrac G, Dixneuf V, Jolliet P: Anti-tumour necrosis factor alpha therapy and increased risk of de novo psoriasis: is it really a paradoxical side effect? Clin Exp Rheumatol, 2012, 30(5):700-6.
Takahashi H, Hashimoto Y, Ishida-Yamamoto A, et al: Psoriasiform and pustular eruption induced by infliximab. J Dermatol, 2007, 34:468–72.
Nestle FO, Conrad C, Tun-Kyi A, et al: Plasmacytoid predendritic cells initiate psoriasis through interferon-production. J Exp Med, 2005, 202:135–43.
Eriksen KW, Lovato P, Skov L, et al: Increased sensitivity to interferon- in psoriatic T cells. J Invest Dermatol, 2005, 125:936–44.
Gilliet M, Conrad C, Geiges M, et al: Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch Dermatol, 2004, 140:1490–5.
Goiriz R, Dauden E, Perez-Gala S, Guhl G, Garcia-Diez A: Flare and change of psoriasis morphology during the course of treatment with tumour necrosis factor blockers. Clin Exp Dermatol, 2007, 32:176–9.
Collamer A N, Battafarano DL: Psoriatic Skin Lesions Induced by Tumor Necrosis Factor Antagonist Therapy: A Literature Review and Potential Mechanisms of Action. Arthritis & Rheumatism (Arthritis Care & Research), 2008, 59(7):996–1001.
DOI: http://dx.doi.org/10.22551/2014.01.0101.10006
Copyright (c)
Archive of Clinical Cases is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
ISSN: 2360-6975